Table 2.
substrate | activity observed | % activitya | % inhibitionb | Eabsolute oxidation (eV) |
---|---|---|---|---|
(HPCA) Homprotocatechuate | Y | 0.2 | 5.40 | |
4-methylcatechol | N | 28 | 5.71 | |
PCA | Y | 100 | 5.82 | |
catechol | Y | 0.17 | 5.88 | |
3,4-dihydroxybenzamide | Y | 33 | 6.11 | |
3,4-dihydroxybenzaldehyde | N | 6.19 | ||
3,4-dihydroxybenzonitrile | Y | 0.04 | 6.30 | |
4-nitrocatechol | N | 31 | 6.46 | |
gallate | Y | 24 | ||
3-O-methylgallate | Y | 3 | ||
2,3,4-trihydroxybenzoic acid | N | 95 | ||
2,3-dihydroxybenzoic acid | N | 36 | ||
3-methoxycatechol | N | 26 |
Measured with 5 mM substrate in air-saturated 50 mM Tris buffer at 25 °C, and pH 7.5. Calculated as a percentage of the activity of LigAB with 5 mM PCA.
Measured with 500 μM PCA and 1 mM inhibitor in air-saturated 50 mM Tris buffer at 25 °C and pH 7.5. Calculated as a percentage of the activity of LigAB with 500 μM PCA with no inhibitor present.